iBionext
Overview
iBionext is a Paris-based venture studio and investment firm dedicated to the creation, development, and financing of innovative startups in the healthcare and deep tech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ChronoLife | Dec 2019 | Seed | Lead |
| Prophesee | Sep 2022 | Series C Extension | Co-investor |
| Tilak Healthcare | Oct 2023 | Series B | Co-investor |
| T-Heart | - | Seed | Lead |
| BrainEver | Nov 2020 | Series A | Co-investor |
Key People
Christophe Bancel
Founder & Venture Partner
Grace Burgess
Co-Founder CEO
Jean-Christophe Dantonel
Managing Partner
Benoit Tamalet
Operating Partner
Stéphane Losik
Middle Office Manager & Investor Support
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is iBionext based?
iBionext is headquartered in Paris, France.
When was iBionext founded?
iBionext was founded in 2016.
How many portfolio companies does iBionext have?
iBionext has 5 portfolio companies in Caplight's dataset.
What are some companies in iBionext's portfolio?
Portfolio companies visible on Caplight include ChronoLife, Prophesee, Tilak Healthcare, T-Heart, BrainEver.
What was iBionext's most recent investment shown here?
iBionext's most recent investment in this portfolio sample was in Tilak Healthcare in 2023.
What sectors does iBionext focus on?
iBionext focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does iBionext focus on?
iBionext typically invests at the Mid stage.
What is iBionext's AUM?
iBionext's assets under management are estimated between $100.0M and $250.0M.